Elon Musk’s Neuralink receives Canadian approval for brain chip trial

Elon Musk’s Neuralink said on Wednesday it has received approval to launch its first clinical trial in Canada for a device designed to give paralysed individuals the ability to use digital devices simply by thinking.

The brain chip startup said the Canadian study aims to assess the safety and initial functionality of its implant which enables people with quadriplegia, or paralysis of all four limbs, to control external devices with their thoughts.